Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Low

Showing results (251-260 of 278) with videos related to

Pageof 28
Sort By:
Vaccine|December 18, 2019
Safety and immunogenicity of a single dose of a tetravalent dengue vaccine with two different serotype-2 potencies in adults in Singapore: A phase 2, double-blind, randomised, controlled trialVianney Tricou, Jenny G Low, Helen M Oh, et al.
Emerging Infectious Diseases|July 1, 2025
Rapid Emergence and Evolution of SARS-CoV-2 Intrahost Variants among COVID-19 Patients with Prolonged Infections, SingaporeYvonne C F Su, Michael A Zeller, Peter Cronin, et al.
Npj Viruses|April 28, 2025
Discordant phylodynamic and spatiotemporal transmission patterns driving the long-term persistence and evolution of human coronavirusesMarcus G Mah, Michael A Zeller, Rong Zhang, et al.
Vaccine|March 25, 2026
Neutralizing antibody titers do not predict T cell response to live-attenuated orthoflaviviral vaccination in humansJustin S G Ooi, Noor Zayanah Hamis, Hwee Cheng Tan, et al.
Vaccine|July 1, 2025
AS01-adjuvanted vaccine alters baseline correlates of T cell response to varicella zoster virus in older adultsCandice C Y Chan, Justin S G Ooi, Clara W T Koh, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 19, 2019
Predictors and Clinical Outcomes of Poor Platelet Recovery in Adult Dengue With Thrombocytopenia: A Multicenter, Prospective StudySophia Archuleta, Po Ying Chia, Yuan Wei, et al.
The New England Journal of Medicine|July 30, 2020
Phase 1 Trial of a Therapeutic Anti-Yellow Fever Virus Human AntibodyJenny G Low, Justin H J Ng, Eugenia Z Ong, et al.
Lancet (London, England)|March 12, 2017
Prophylactic platelet transfusion plus supportive care versus supportive care alone in adults with dengue and thrombocytopenia: a multicentre, open-label, randomised, superiority trialDavid C Lye, Sophia Archuleta, Sharifah F Syed-Omar, et al.
The Journal of Infectious Diseases|September 30, 2019
Adenoviral Infections in Singapore: Should New Antiviral Therapies and Vaccines Be Adopted?Kristen K Coleman, Chui Ching Wong, Jayanthi Jayakumar, et al.
Med (New York, N.Y.)|September 9, 2025
Dengue virus infection reprograms baseline innate immune gene expressionEugenia Z Ong, Jia Xin Yee, Clara W Koh, et al.
Pageof 28

Showing results (251-260 of 278) with videos related to

Sort By:
Pageof 28
Vaccine|December 18, 2019
Safety and immunogenicity of a single dose of a tetravalent dengue vaccine with two different serotype-2 potencies in adults in Singapore: A phase 2, double-blind, randomised, controlled trialVianney Tricou, Jenny G Low, Helen M Oh, et al.
Emerging Infectious Diseases|July 1, 2025
Rapid Emergence and Evolution of SARS-CoV-2 Intrahost Variants among COVID-19 Patients with Prolonged Infections, SingaporeYvonne C F Su, Michael A Zeller, Peter Cronin, et al.
Npj Viruses|April 28, 2025
Discordant phylodynamic and spatiotemporal transmission patterns driving the long-term persistence and evolution of human coronavirusesMarcus G Mah, Michael A Zeller, Rong Zhang, et al.
Vaccine|March 25, 2026
Neutralizing antibody titers do not predict T cell response to live-attenuated orthoflaviviral vaccination in humansJustin S G Ooi, Noor Zayanah Hamis, Hwee Cheng Tan, et al.
Vaccine|July 1, 2025
AS01-adjuvanted vaccine alters baseline correlates of T cell response to varicella zoster virus in older adultsCandice C Y Chan, Justin S G Ooi, Clara W T Koh, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 19, 2019
Predictors and Clinical Outcomes of Poor Platelet Recovery in Adult Dengue With Thrombocytopenia: A Multicenter, Prospective StudySophia Archuleta, Po Ying Chia, Yuan Wei, et al.
The New England Journal of Medicine|July 30, 2020
Phase 1 Trial of a Therapeutic Anti-Yellow Fever Virus Human AntibodyJenny G Low, Justin H J Ng, Eugenia Z Ong, et al.
Lancet (London, England)|March 12, 2017
Prophylactic platelet transfusion plus supportive care versus supportive care alone in adults with dengue and thrombocytopenia: a multicentre, open-label, randomised, superiority trialDavid C Lye, Sophia Archuleta, Sharifah F Syed-Omar, et al.
The Journal of Infectious Diseases|September 30, 2019
Adenoviral Infections in Singapore: Should New Antiviral Therapies and Vaccines Be Adopted?Kristen K Coleman, Chui Ching Wong, Jayanthi Jayakumar, et al.
Med (New York, N.Y.)|September 9, 2025
Dengue virus infection reprograms baseline innate immune gene expressionEugenia Z Ong, Jia Xin Yee, Clara W Koh, et al.
Pageof 28